USA flag logo/image

An Official Website of the United States Government

AN IMPROVED BIOARTIFICIAL ENDOCRINE PANCREAS

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
13803
Program Year/Program:
1990 / SBIR
Agency Tracking Number:
13803
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Cellular Transplants Inc
4 Richmond Sq Providence, RI 02906
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1990
Title: AN IMPROVED BIOARTIFICIAL ENDOCRINE PANCREAS
Agency: HHS
Contract: N/A
Award Amount: $49,938.00
 

Abstract:

THE LONG-TERM OBJECTIVE OF THIS RESEARCH IS THE DEVELOPMENT AND INTRODUCTION TO MEDICAL PRACTICE OF AN EFFECTIVE BIOCOMPATIBLE IMPLANTABLE HYBRID ARTIFICIAL ENDOCRINE PANCREAS THAT IS CAPABLE OF SIGNIFICANT IMPROVEMENT IN THE THERAPY OF INSULIN-DEPENDENT DIABETES. THE SPECIFIC AIM OF THIS PROJECT IS TO EXTEND AND MODIFY A PROCESS FOR CELLULAR ENCAPSULATION TO THE ISLETS OF LANGERHANS, USING A CO-EXTRUSION METHOD IN WHICH THE ISLET TISSUE IS ENCLOSED WITHIN THE POLYMERIC MEMBRANE CAPSULE AT THE TIME OF ITS FORMATION. THE RESEARCH PROGRAM WILL DEFINE CONDITIONS OF A MACROCAPSULE CONTAINING PHYSIOLOGICALLY RESPONSIVE INSULIN-SECRETING ENDOCRINE TISSUE. DEVELOPMENT OF THIS TECHNOLOGY MAY PERMIT THE EFFICACIOUS USE OF ANIMAL CELLS INAN IMMUNOISOLATED ENVIRONMENT FOR THE EARLY TREATMENT OF INSULIN-DEPENDENT DIABETES AND THUS IMPACT POSITIVELY ON THEPREVENTION OF THE DEBILITATING SECONDARY COMPLICATIONS ASSOCIATED WITH THE DISEASE.

Principal Investigator:

Orion D Hegre
4012723310

Business Contact:

Small Business Information at Submission:

Cellular Transplants Inc
4 Richmond Sq Providence, RI 02906

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No